Companies › EW
EDWARDS LIFESCIENCES CORP (EW)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001099800 · EDGAR filings · Updated 2026-07-28
EDWARDS LIFESCIENCES CORP (EW) has reported institutional ownership of 87.5%, with 1,280 institutional managers holding positions valued at $40.3B per the latest 13F reporting period.
Filings this week (5)
- 2026-07-28 — Notice of proposed sale filed (Form 144)
- 2026-07-28 — Insider transaction reported (Form 4)
- 2026-07-27 — Insider transaction reported (Form 4)
- 2026-07-27 — Notice of proposed sale filed (Form 144)
- 2026-07-23 — Current report (8-K) filed
Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.
Latest updates
- 2026-07-13 — Insider transaction reported (Form 4)
- 2026-07-10 — Insider transaction reported (Form 4)
- 2026-07-10 — Insider transaction reported (Form 4)
- 2026-07-07 — Insider transaction reported (Form 4)
- 2026-06-30 — Insider transaction reported (Form 4)
- 2026-06-17 — Insider transaction reported (Form 4)
- 2026-06-12 — 11-K filed
- 2026-06-12 — 11-K filed
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, EDWARDS LIFESCIENCES CORP has 1,280 institutional holders and institutional ownership of 87.5%.
| # | Institution | Reported value | % of tracked total |
|---|---|---|---|
| 1 | BlackRock, Inc. | $4.21B | 10.4% |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | $3.02B | 7.5% |
| 3 | VANGUARD PORTFOLIO MANAGEMENT LLC | $2.11B | 5.2% |
| 4 | STATE STREET CORP | $2.11B | 5.2% |
| 5 | WELLINGTON MANAGEMENT GROUP LLP | $1.76B | 4.4% |
| 6 | JPMORGAN CHASE & CO | $1.73B | 4.3% |
| 7 | Bank of New York Mellon Corp | $1.34B | 3.3% |
| 8 | FMR LLC | $1.16B | 2.9% |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | $1.05B | 2.6% |
| 10 | JENNISON ASSOCIATES LLC | $1.05B | 2.6% |
Full holder history and quarter-over-quarter changes are available inside the app.
Insider activity
Insiders reported 127 transactions (0 buys, 37 sells) across 17 reporting insiders, with a net reported value of −$18.9M.
Quarterly net insider value, as reported in Form 4 filings.
Related companies
ZOETIS INC (ZTS) · ALNYLAM PHARMACEUTICALS INC (ALNY) · BECTON DICKINSON & CO (BDX) · IDEXX LABS INC (IDXX) · INSMED INC (INSM) · WATERS CORP (WAT)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-28.